Proteins

Cancer cells
#Funding #Immunotherpy #NeoPhore #Proteins #Small molecules

Financing extension for neoantigen immuno-oncology company 

NeoPhore has announced a further extension of £9.6 million (approximately $12.2 million) to its Series B financing round, bringing the total raised to £31.1 million (approximately $39.5 million).  The company is building a pipeline of small molecule drugs targeting novel proteins across the DNA mismatch repair (MMR) pathway to generate… Read More

#Business & Investment #Cancer Research #News

amino acids chain
#Biologics #Drug discovery #Infographic #Nanomedicine / nanotechnology #Proteins

Compare methods for thermal stability assessment of proteins

A new infographic ‘Four methods for thermal stability assessment of therapeutic proteins‘ is now available to download for free. Thermal stability is among the most common critical quality attributes (CQAs) used for early developability assessment of biologics. In this infographic, learn about four methods for thermal stability… Read More

#News

#Biologics #Drug discovery #Infographic #Nanomedicine / nanotechnology #Proteins

Four methods for thermal stability assessment of proteins

Thermal stability is among the most common critical quality attributes (CQAs) used for early developability assessment of biologics. In this infographic, learn about four methods for thermal stability assessment of proteins – what they measure, what the data tells you, and their benefits and limitations. While each provides unique value,… Read More

#Intelligence #Resources

Flower of Oldenlandia monanthos
#Drug discovery #Plant-based #Proteins #University of Bath

Can a plant-based discovery pave the way for new drug treatments?

Scientists at the University of Bath have developed a way of joining up the head and tail of a protein, making it more stable and easier to get into cells. This new tool may help researchers develop new pharmaceuticals in a cleaner, greener, and less expensive way. Drug treatments often… Read More

#News

#Biosecurity #Cell programming #Defense Advanced Research Projects Agency #Ginkgo Bioworks #Proteins #Therapeutic proteins #Therapeutics

Ginkgo Bioworks awarded DARPA contract for therapeutic proteins 

The Defense Advanced Research Projects Agency (DARPA) has announced that Ginkgo Bioworks, which is building a platform for cell programming and biosecurity, has been awarded a four-year contract worth up to $18 million to reimagine how to manufacture complex therapeutic proteins.   As a performer on DARPA's Reimagining Protein Manufacturing… Read More

#News #Regulatory

#AI / data analytics / healthtech / informatics #Data science #Lab automation #Life science #Machine learning #Proteins #Proteomics #SLAS2023 #Therapeutics

Don’t miss the DDW Events podcast series for SLAS2023

Today marks the start of SLAS2023 in San Diego. Over the last week, DDW’s Megan Thomas has narrated five articles from the SLAS2023 supplement as part of the DDW Events podcast series. Episodes include: A Welcome to SLAS 2023 Acquiring deeper insights and acceleration with AI Connecting… Read More

#News

#Biomedicine #Cloud computing #High throughput screening #Lab automation #Life sciences #Machine learning #Proteins #Proteomics #SLAS2023 #Therapeutics

Podcast: ML and lab automation are changing protein therapeutics

Ahead of this year’s SLAS2023 conference in San Diego (which takes place 25 February – 1 March) DDW’s Megan Thomas narrates articles from the DDW SLAS2023 supplement as part of the DDW Events podcast series. This is episode four, How machine learning and lab automation are changing the… Read More

#News

Protein
#AI / data analytics / healthtech / informatics #Artificial intelligence (AI) #BioInnovation Institute #Biologics / Biotechnology #Investment #Proteins #Start-ups

Therapeutic protein project joins Bio Studio programme

A project creating a new class of therapeutic proteins to modulate cell signalling has been accepted into the BioInnovation Institute (BII) Bio Studio programme. The project is based on recent breakthroughs in artificial intelligence (AI) and protein design, and uses methods pioneered by David Baker’s laboratory at the University of… Read More

#News #Start-up Zone

Laboratory mouse
#Genetics / genomics #Japan #Mouse models #Muscles #Proteins

Study could pave way for new muscle atrophy treatments

Researchers have identified the genetic links between muscle atrophy and two types of myosin, paving the way for a new disease model for scientific research and potential new treatments.  The synergistic action of the muscle proteins myosin and actin enables skeletal muscle movements. The skeletal muscle myosin… Read More

#News

Excitatory/inhibitory neuronal reporter
#Gene delivery #Gene expression #Gene therapy #Precision medicine #Proteins

Gene expression delivery tool ‘slides’ instructions into cells

Researchers say they have successfully used a cell’s natural process for making proteins to ‘slide’ genetic instructions into a cell and produce critical proteins missing from those cells.   If further studies verify the results, this could be a new method for targeting specific cell types for a… Read More

#News #Trending News

Click chemistry
#Biomarkers #Bioorthogonal chemistry #Click chemistry #Genetic engineering #Proteins

‘Click’ chemistry used to tag proteins made by cancer cells 

A new method to study the proteins released by cells, which could lead to new biomarkers for diseases including cancer, has been developed by scientists at the Francis Crick Institute and Imperial College London.   Biomarkers are valuable tools in diagnosing disease or predicting treatment outcomes, but they are… Read More

#Cancer Research #News

Bananas
#Antivirals #Genetic engineering #Immunology / Virology & Vaccines #Proteins

Engineered banana lectin could become broad spectrum antiviral 

An international team of scientists have engineered protein banana lectin, or BanLec, to create a new version that can fight off a range of viruses without unwanted side effects.  The genetically engineered version has been called H84T and worked against the viruses that cause AIDS, hepatitis… Read More

#News

Protein
#Drug discovery #ELRIG #Events #Protein Science #Proteins

Event: Protein sciences in drug discovery

The 2022 Protein Science in Drug Discovery ELRIG meeting will be held at The Babraham Research Campus, Cambridge UK from 2-3 November 2022. The meeting will host leading scientists from industry and academia and will aim to focus on the application of emerging areas of Protein Science to the challenges of… Read More

#News

#cryo-microscopy #Drug discovery #Proteins #Webinar

Webinar: Impact of cryo-EM on high resolution structure biology

Don’t miss the opportunity to register for this exclusive DDW event High resolution electron cryo-microscopy: From membrane proteins to diseases, supported by Thermo Fisher Scientific. The webinar will take place on 19 October, 2022, 4PM BST, 8AM PDT. Discover how cryo-EM is impacting high… Read More

#News

#cryo-microscopy #Drug discovery #Proteins #Webinar

High resolution electron cryo-microscopy: register now

Join DDW for a webinar that will demonstrate how cryo-EM is impacting high resolution structure biology from membrane proteins to diseases including Alzheimer’s disease and cancer therapeutics by showing high-resolution structures of these proteins bound to inhibitors.  The exclusive free event High resolution electron cryo-microscopy: From… Read More

#News

#cryo-microscopy #Drug discovery #Proteins #Webinar

Webinar: Discover the implications of atomic resolution cryo-EM

Join DDW for this exclusive free event High resolution electron cryo-microscopy: From membrane proteins to diseases, supported by Thermo Fisher Scientific, which will take place on 19 October, 2022, 4PM BST, 8AM PDT. Discover how cryo-EM is impacting high resolution structure biology from membrane proteins… Read More

#News